204 results
Page 2 of 11
20-F/A
kmcdhjln y0kijdivv
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
na89aqdft5 zg
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
9fxokmyzqu6s haw
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
up4392lnkomm0k
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
d3gsazrh18sy7
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
vhoguzwan4j
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
gka4is1owph 56
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
kj88kc
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
9nhwn
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
lblo8
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
p8z9p7d
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
cywy 52rzwclb
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.4
4el2bx3
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
jwgeb20evd
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
nlsu4c
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
2swi7ih87y getm
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
one9jaqn
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
hlok srofypz7
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
i6gl9
21 Dec 21
51-102F3 Material Change Report
5:28pm